3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Dermatologic
1
Conditions
Keratosis, Actinic
4
Neoplasms
2
Keratosis
2
Stomach Neoplasms
1
Precancerous Conditions
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Carcinoma
1
Breast Neoplasms
1
Bone-Metastatic, Castration-Resistant Prostate Cancer
1
Interventions
Aminolevulinic Acid
2
tirbanibulin
1
ruxolitinib
1
human papillomavirus vaccine, L1 type 16, 18
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Toremifene
1
Robotic Surgical Procedures
1
Pregnancy Tests
1
Hysterectomy
1
Human Papillomavirus DNA Tests
1
Excipients
1
Colposcopy
1
Celecoxib
1
CPI-0610
1
Blood Specimen Collection
1
Biopsy
1
BF-200 ALA
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Precancerous Conditions
×
tirbanibulin
×
Clear all
NCT06135415
2026-03-25
TirbAKare
Almirall, S.A.
Phase 3
Completed
280 enrolled